FDA Inspection 794472 — Lotte Biologics USA, LLC

Lotte Biologics USA, LLC — FEI 1317757

The FDA completed an inspection of Lotte Biologics USA, LLC on July 20, 2012 in East Syracuse, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 20, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
East Syracuse, NY (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
1570621 CFR 111.325(a)Laboratory operations: electronic
203121 CFR 211.194(a)Complete test data included in records